002382 藍帆醫療
按盤價 
5.320 +0.430 (+8.793%)
5.320 +0.430 (+8.793%) | 2024/06 - 中期 人民幣(K¥) | 與去年同期 比較 | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | 2020/12 人民幣(K¥) | ||
| 營業總收入 | 3,005,595 | 32.88% | 4,927,075 | 4,900,478 | 8,108,586 | 7,869,425 | |
| 減：營業總成本 | 3,171,296 | 22.89% | 5,560,762 | 5,524,116 | 5,727,872 | 4,088,485 | |
| 其中:營業成本 | 2,518,802 | 26.59% | 4,320,997 | 4,398,973 | 4,301,551 | 2,801,370 | |
| 財務費用 | 95,015 | 27.13% | 124,258 | 33,873 | 167,490 | 280,111 | |
| 資產減值損失 | (12,509) | -68.60% | (72,256) | (82,338) | (2,117,249) | (1,769,164) | |
| 公允價值變動收益 | 35 | -99.95% | 70,628 | (6,742) | 1,098,472 | 1,057 | |
| 投資收益 | (7,232) | -144.56% | 14,408 | 257,712 | 24,309 | 36,100 | |
| 其中：對聯營企業和合營企業的投資收益 | (7,563) | -183.87% | 4,438 | (24,104) | 2,527 | 32,001 | |
| 營業利潤 | (181,280) | -29.95% | (604,846) | (402,079) | 1,390,548 | 2,038,479 | |
| 利潤總額 | (166,381) | -33.59% | (622,610) | (405,860) | 1,347,358 | 2,018,388 | |
| 減：所得稅費用 | 2,077 | -114.91% | (54,250) | (33,544) | 191,649 | 255,344 | |
| 淨利潤 | (168,458) | -28.80% | (568,360) | (372,316) | 1,155,709 | 1,763,044 | |
| 減：非控股權益 | (8,241) | -- | -- | -0 | (1) | 4,567 | |
| 股東淨利潤 | (160,217) | -32.29% | (568,360) | (372,316) | 1,155,709 | 1,758,477 | |
市場價值指標 | |||||||
| 每股收益 (元) * | -0.160 | -30.43% | -0.560 | -0.370 | 1.130 | 1.820 | |
| 每股派息 (元) * | -- | -- | -- | 0.400 | -- | 0.400 | |
| 每股淨資產 (元) * | 8.734 | -10.80% | 9.294 | 10.290 | -- | 9.579 | |
| 審計意見 # | -- | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | -- | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 報價延遲最少15分鐘，資料更新時間為 30/09/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
